Heather B Neuman, MD, MS, FACS
Associate Professor
- Division of Surgical Oncology
neuman@surgery.wisc.edu
(608) 263-7064
- Breast Center: (608) 266-6400
- Administrative Assistant: (608) 262-2025
600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792
Education
- MD, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2000
- Surgical Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY, 2007-2009
- Residency in General Surgery, University of North Carolina, Chapel Hill, NC, 2000-2005
- National Research Service Award Fellow, Agency for Healthcare Research and Quality, Weill Medical College of Cornell University, New York, NY, 2005-2007
- Research Fellow in Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2007
- MS, Weill Graduate School in Medical Sciences of Cornell University, New York, NY, 2007
Clinical Specialties
Dr. Neuman specializes in surgical oncology with a focus on breast, melanoma and sarcoma. She is certified by the American Board of Surgery.
Dr. Neuman provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Lymph Node Dissection, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Modified Radical Mastectomy, Needle-localized Biopsy, Needle-localized Excision, Radical Resection Soft Tissue Tumor, Sarcoma Removal of Retroperitoneal/intraabdominal Soft Tissue Tumors (Sarcomas), Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy, Wide Local Excision Skin With Reconstruction.
Research Interests
Dr. Neuman’s research focuses on patient-oriented clinical outcomes including patient decision-making, quality of life and survivorship. Her primary research uses mixed methods to improve the quality and efficiency of breast cancer follow-up provided to breast cancer survivors. Secondary research interests include the use of decision aids to improve patient decision-making surrounding breast cancer surgery. Additionally, she is the principal investigator for a number of surgical clinical trials focused on melanoma.
Recent Publications
ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II.
Jakub JW, Lowe M, Harrison Howard J, Farma JM, Sarnaik A, Tuttle T, Neuman HB, Ariyan CE, Uppal A, Trocha S, Beasley GM, Wasif N, Bilimoria KY, Thomay AA, Allred JB, Chen L, Terando AM, Wayne JD, Thompson JF, Cochran AJ, Sim MS, Elashoff DE, Delman KA, Faries MB
Ann Surg Oncol 2022 May 12;
[PubMed ID: 35552927]ASO Visual Abstract: Incidence of Second Primary Melanoma in Survivors of Cutaneous Melanoma.
Wiener AA, Schumacher JR, Racz JM, Weber SM, Xu YG, Neuman HB
Ann Surg Oncol 2022 May 11;
[PubMed ID: 35545725]ASO Author Reflections: Counseling Melanoma Survivors on the Risk of a Second Melanoma.
Wiener AA, Schumacher JR, Neuman HB
Ann Surg Oncol 2022 May 06;
[PubMed ID: 35524082]Incidence of Second Primary Melanoma in Cutaneous Melanoma Survivors.
Wiener AA, Schumacher JR, Racz JM, Weber SM, Xu YG, Neuman HB
Ann Surg Oncol 2022 May 03;
[PubMed ID: 35505144]Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
Jakub JW, Lowe M, Howard JH, Farma JM, Sarnaik A, Tuttle T, Neuman HB, Ariyan CE, Uppal A, Trocha S, Beasley GM, Wasif N, Bilimoria KY, Thomay AA, Allred JB, Chen L, Terando AM, Wayne JD, Thompson JF, Cochran AJ, Sim MS, Elashoff DE, Delman KA, Faries MB
Ann Surg Oncol 2022 May 02;
[PubMed ID: 35499783]